ESTUTC-5 New YorkLog in Sign up

BIAF
bioAffinity Technologies, Inc. Common Stock
stockNASDAQ

Market OpenNov 11, 2026 12:22:11 PM EST

2.27USD-5.021%(-0.12)32,210

Pre-marketNov 11, 2026 9:19:30 AM EST

2.4425USD+2.197%(+0.0525)

2.0200Bid2.8700Ask0.8500Spread

BIAF News

Day breaks

08:00 AM ESTbioAffinity Technologies Reports Record Monthly Testing Volume in October for Its Noninvasive CyPath® Lung Test ·

Business Wire

05:46 PM ESTbioAffinity Technologies GAAP EPS of -$5.89, revenue of $1.1M ·

Seeking Alpha

05:40 PM ESTbioAffinity Technologies Reports Third Quarter 2026 Results and Continued Momentum in CyPath® Lung Commercialization ·

Business Wire

12:30 PM EDTWallachBeth Capital Announces Closing of bioAffinity Technologies $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules ·

PR Newswire

01:30 PM EDTWallachBeth Capital Announces bioAffinity Technologies Approximately $4 Million Registered Direct Financing of Common Stock and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules ·

PR Newswire

08:00 AM EDTbioAffinity Technologies Promotes Veteran Awareness and Access to Its Noninvasive CyPath® Lung Cancer Test Through Distribution Partnership with Veteran-Owned AvMEDICAL ·

Business Wire

08:00 AM EDTbioAffinity Technologies to Present Positive Clinical and Veteran-Focused Data on CyPath® Lung at NAVREF 2026 Annual Conference ·

Business Wire

05:01 PM EDTbioAffinity Technologies宣布其CyPath® Lung非侵入性肺癌診斷產品獲得香港專利授權 ·

Business Wire

08:00 AM EDTbioAffinity Technologies Announces Grant of Hong Kong Patent for Company's CyPath® Lung Noninvasive Lung Cancer Diagnostic ·

Business Wire